British Journal of Cancer - Table of Contents alert Volume 111 Issue 7

If you are unable to see the message below, click here to view.

TABLE OF CONTENTS Volume 111, Issue 7 (1249-1468) Published online 23 September 2014 In this issue Minireviews Clinical Studies Translational Therapeutics Molecular Diagnostics Epidemiology Also new today Advance online publication Digital Edition Sign up for e-alerts Recommend to your library Web feed Subscribe Advertisement Don't miss out! Discover which British Journal of Cancer articles your colleagues are reading — view the top ten now.  Top ten Articles     Minireviews Top Androgen metabolism in prostate cancer: from molecular mechanisms to clinical consequences K-H Chang, C E Ercole and N Sharifi Br J Cancer 2014 111: 1249-1254; advance online publication, May 27, 2014; 10.1038/bjc.2014.268 Abstract | Full Text Eph receptors as therapeutic targets in glioblastoma B W Day, B W Stringer and A W Boyd Br J Cancer 2014 111: 1255-1261; advance online publication, August 21, 2014; 10.1038/bjc.2014.73 Abstract | Full Text Clinical Studies Top Refinement of the Symptom Screening in Pediatrics Tool (SSPedi) C O’Sullivan, L L Dupuis, P Gibson, D L Johnston, C Baggott, C Portwine, B Spiegler, S Kuczynski, D Tomlinson, S de Mol Van Otterloo, G A Tomlinson and L Sung Br J Cancer 2014 111: 1262-1268; advance online publication, August 7, 2014; 10.1038/bjc.2014.445 Abstract | Full Text BRCA1 mRNA levels following a 4–6-week intervention with oral 3,3′-diindolylmethane J Kotsopoulos, S Zhang, M Akbari, L Salmena, M Llacuachaqui, M Zeligs, P Sun and S A Narod Br J Cancer 2014 111: 1269-1274; advance online publication, July 15, 2014; 10.1038/bjc.2014.391 Abstract | Full Text Concurrent analysis of human equilibrative nucleoside transporter 1 and ribonucleotide reductase subunit 1 expression increases predictive value for prognosis in cholangiocarcinoma patients treated with adjuvant gemcitabine-based chemotherapy H Sasaki, Y Murakami, K Uemura, T Sudo, Y Hashimoto, N Kondo and T Sueda Br J Cancer 2014 111: 1275-1284; advance online publication, July 17, 2014; 10.1038/bjc.2014.399 Abstract | Full Text Redefining high-risk patients with stage II colon cancer by risk index and microRNA-21: results from a population-based cohort T F Hansen, S Kjær-Frifeldt, R D Christensen, S Morgenthaler, T Blondal, J Lindebjerg, F B Sørensen and A Jakobsen Br J Cancer 2014 111: 1285-1292; advance online publication, July 22, 2014; 10.1038/bjc.2014.409 Abstract | Full Text Chromatin structure, transcriptional activity and DNA repair efficiency affect the outcome of chemotherapy in multiple myeloma M Gkotzamanidou, P P Sfikakis, S A Kyrtopoulos, C Bamia, M A Dimopoulos and V L Souliotis Br J Cancer 2014 111: 1293-1304; advance online publication, July 22, 2014; 10.1038/bjc.2014.410 Abstract | Full Text The lag time in initiating clinical testing of new drugs in combination with radiation therapy, a significant barrier to progress? P Blumenfeld, R M Pfeffer, Z Symon, R B Den, A P Dicker, D Raben and Y R Lawrence Br J Cancer 2014 111: 1305-1309; advance online publication, August 12, 2014; 10.1038/bjc.2014.448 Abstract | Full Text Translational Therapeutics Top Dasatinib worsens the effect of cetuximab in combination with fractionated radiotherapy in FaDu- and A431-derived xenografted tumours M Baro, L I de Llobet, A Figueras, I Skvortsova, R Mesia and J Balart Br J Cancer 2014 111: 1310-1318; advance online publication, July 31, 2014; 10.1038/bjc.2014.432 Abstract | Full Text Preferential potentiation of topoisomerase I poison cytotoxicity by PARP inhibition in S phase P Znojek, E Willmore and N J Curtin Br J Cancer 2014 111: 1319-1326; advance online publication, July 8, 2014; 10.1038/bjc.2014.378 Abstract | Full Text Negative regulation of signal transducer and activator of transcription-3 signalling cascade by lupeol inhibits growth and induces apoptosis in hepatocellular carcinoma cells K S Siveen, A H Nguyen, J H Lee, F Li, S S Singh, A P Kumar, G Low, S Jha, V Tergaonkar, K S Ahn and G Sethi Br J Cancer 2014 111: 1327-1337; advance online publication, August 7, 2014; 10.1038/bjc.2014.422 Abstract | Full Text Prostate cancer cell malignancy via modulation of HIF-1α pathway with isoflurane and propofol alone and in combination H Huang, L L Benzonana, H Zhao, H R Watts, N J S Perry, C Bevan, R Brown and D Ma Br J Cancer 2014 111: 1338-1349; advance online publication, July 29, 2014; 10.1038/bjc.2014.426 Abstract | Full Text Adaptive immune contexture at the tumour site and downmodulation of circulating myeloid-derived suppressor cells in the response of solitary fibrous tumour patients to anti-angiogenic therapy M Tazzari, T Negri, F Rini, B Vergani, V Huber, A Villa, P Dagrada, C Colombo, M Fiore, A Gronchi, S Stacchiotti, P G Casali, S Pilotti, L Rivoltini and C Castelli Br J Cancer 2014 111: 1350-1362; advance online publication, August 7, 2014; 10.1038/bjc.2014.437 Abstract | Full Text Molecular Diagnostics Top Prognostic significance of epithelial–mesenchymal transition-related markers in extrahepatic cholangiocarcinoma: comprehensive immunohistochemical study using a tissue microarray T Nitta, T Mitsuhashi, Y Hatanaka, M Miyamoto, K Oba, T Tsuchikawa, Y Suzuki, K C Hatanaka, S Hirano and Y Matsuno Br J Cancer 2014 111: 1363-1372; advance online publication, July 31, 2014; 10.1038/bjc.2014.415 Abstract | Full Text Lack of BAP1 protein expression in uveal melanoma is associated with increased metastatic risk and has utility in routine prognostic testing H Kalirai, A Dodson, S Faqir, B E Damato and S E Coupland Br J Cancer 2014 111: 1373-1380; advance online publication, July 24, 2014; 10.1038/bjc.2014.417 Abstract | Full Text Chromosome 9p deletion in clear cell renal cell carcinoma predicts recurrence and survival following surgery I El-Mokadem, J Fitzpatrick, J Bondad, P Rauchhaus, J Cunningham, N Pratt, S Fleming and G Nabi Br J Cancer 2014 111: 1381-1390; advance online publication, August 19, 2014; 10.1038/bjc.2014.420 Abstract | Full Text PD-1+ CD8+ T cells are exhausted in tumours and functional in draining lymph nodes of colorectal cancer patients X Wu, H Zhang, Q Xing, J Cui, J Li, Y Li, Y Tan and S Wang Br J Cancer 2014 111: 1391-1399; advance online publication, August 5, 2014; 10.1038/bjc.2014.416 Abstract | Full Text Exogenous IGFBP-2 promotes proliferation, invasion, and chemoresistance to temozolomide in glioma cells via the integrin β1-ERK pathway S Han, Z Li, L M Master, Z W Master and A Wu Br J Cancer 2014 111: 1400-1409; advance online publication, August 5, 2014; 10.1038/bjc.2014.435 Abstract | Full Text Epidemiology Top The risk of cancer in primary care patients with hypercalcaemia: a cohort study using electronic records F Hamilton, R Carroll, W Hamilton and C Salisbury Br J Cancer 2014 111: 1410-1412; advance online publication, August 5, 2014; 10.1038/bjc.2014.433 Abstract | Full Text Risk of leukaemia or cancer in the central nervous system among children living in an area with high indoor radon concentrations: results from a cohort study in Norway R Del Risco Kollerud, K G Blaasaas and B Claussen Br J Cancer 2014 111: 1413-1420; advance online publication, August 12, 2014; 10.1038/bjc.2014.400 Abstract | Full Text Prostate cancer risk and nonsteroidal antiinflammatory drug use in the Finnish prostate cancer screening trial T Veitonmäki, T J Murtola, L Määttänen, K Taari, U-H Stenman, T L J Tammela and A Auvinen Br J Cancer 2014 111: 1421-1431; advance online publication, July 10, 2014; 10.1038/bjc.2014.381 Abstract | Full Text Association between diabetes, diabetes treatment and risk of developing endometrial cancer J Luo, S Beresford, C Chen, R Chlebowski, L Garcia, L Kuller, M Regier, J Wactawski-Wende and K L Margolis Br J Cancer 2014 111: 1432-1439; advance online publication, July 22, 2014; 10.1038/bjc.2014.407 Abstract | Full Text Evaluation of a service intervention to improve awareness and uptake of bowel cancer screening in ethnically-diverse areas J Shankleman, N J Massat, L Khagram, S Ariyanayagam, A Garner, S Khatoon, S Rainbow, S Rangrez, Z Colorado, W Hu, D Parmar and S W Duffy Br J Cancer 2014 111: 1440-1447; advance online publication, July 1, 2014; 10.1038/bjc.2014.363 Abstract | Full Text Associations between human papillomavirus and history of cancer among U.S. adults in the National Health and Nutrition Examination Survey (2003–2010) B Liu and E Taioli Br J Cancer 2014 111: 1448-1453; advance online publication, July 24, 2014; 10.1038/bjc.2014.414 Abstract | Full Text Spanish Mediterranean diet and other dietary patterns and breast cancer risk: case–control EpiGEICAM study A Castelló, M Pollán, B Buijsse, A Ruiz, A M Casas, J M Baena-Cañada, V Lope, S Antolín, M Ramos, M Muñoz, A Lluch, A de Juan-Ferré, C Jara, M A Jimeno, P Rosado, E Díaz, V Guillem, E Carrasco, B Pérez-Gómez, J Vioque, H Boeing and M Martín Br J Cancer 2014 111: 1454-1462; advance online publication, August 7, 2014; 10.1038/bjc.2014.434 Abstract | Full Text Overdiagnosis due to breast cancer screening: updated estimates of the Helsinki service study in Finland S Heinävaara, T Sarkeala and A Anttila Br J Cancer 2014 111: 1463-1468; advance online publication, August 14, 2014; 10.1038/bjc.2014.413 Abstract | Full Text Please note that you need to be a subscriber or site-licence holder to enjoy full-text access to British Journal of Cancer. In order to do so, please purchase a subscription. You have been sent this Table of Contents Alert because you have opted in to receive it. You can change or discontinue your e-mail alerts at any time, by modifying your preferences on your nature.com account at: www.nature.com/nams/svc/myaccount (You will need to log in to be recognised as a nature.com registrant). For further technical assistance, please contact our registration department. For print subscription enquiries, please contact our subscription department. For other enquiries, please contact our customer feedback department. Nature Publishing Group | 75 Varick Street, 9th Floor | New York | NY 10013-1917 | USA Nature Publishing Group's worldwide offices: London - Paris - Munich - New Delhi - Tokyo - Melbourne San Diego - San Francisco - Washington - New York - Boston Macmillan Publishers Limited is a company incorporated in England and Wales under company number 785998 and whose registered office is located at Brunel Road, Houndmills, Basingstoke, Hampshire RG21 6XS. © 2014 Nature Publishing Group, a division of Macmillan Publishers Limited. All Rights Reserved.